Avance Clinical Wins Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award
- 2020年07月09日 03:30:00
- テクノロジー
- JCN Newswire
According to Frost &Sullivan:
"The Frost &Sullivan Best Practices Awards have honoured best-in-class companies that have demonstrated excellence in their respective industries. Award recipients were identified based on in-depth interviews, analysis, and extensive secondary research conducted by Frost &Sullivan analysts and companies are typically studied on their revenues, market share, capabilities, and overall contribution to the industry to identify best practices."
Avance Clinical CEO Yvonne Lungershausen:
Commending her team of more than 100 clinical trial specialists throughout Australia and New Zealand, "We have shown, with our repeat business rate greater than 75%, that our consistent sponsor focussed culture and nimble proactive approach wins every time. This has been recognised by the research team at Frost &Sullivan and the entire Avance Clinical team are very proud.
"Australia, which has successfully managed the COVID-19 crisis, is open for business for clinical trials. This award further reinforces to the biotech community that this is an early phase specialist destination where they can turn around delayed trials. Avance Clinical are experts in facilitating fast study startup with trials typically approved and initiated in under 6 weeks."
Avance Clinical has been providing high-quality clinical research services fit for global regulatory standards to the local and international drug development industry for 20 years. Avance specialises in supporting biotech companies with their early phase clinical trials, having conducted over 150 early phase (Phase 1 &2) trials in the past 4 years, involving the treatment of 8,300 participants across 95 therapeutic indications.
According to Nidhi Jalali, Analyst Best Practices, Frost &Sullivan:
"Within Asia-Pacific's highly competitive CRO market, Avance Clinical stands out as a leader in early phase biotech clinical trials. Avance's reputation for high-quality clinical trial outcomes has attracted an impressive 74% repeat business rate, underscoring the company's position as a market leader.
Avance Clinical offers a highly responsive and proactive service for biotechs wanting rapid and innovative clinical trial solutions, with the highest level of data compliance. The company has grown quickly over the past year doubling staff numbers, with plans to further expand. Avance Clinical offers a real size match for biotechs, meaning better mission understandings and stronger customer service compared to the larger CROs."
In addition to the impressive COVID-19 management in Australia, a key factor in sponsor demand is the speed, access to high-quality sites and attractive cost of running trials in Australia including:
- The Australian Government financial rebate of up to 43.5% on clinical trial spend
- No IND required for clinical trials and streamlined regulatory processes
- Advanced medical, research and scientific community, leading investigators &KOLs, modern medical facilities
Australia's reputation for FDA compliant scientific and research excellence, its advanced healthcare, and the opportunity to access patients in a less clinical trial competitive environment further reinforces its advantage as a destination for clinical trials.
Learn about running your next study with Avance Clinical: https://www.avancecro.com/.
About the Frost &Sullivan Awards
The Frost &Sullivan 2020 Best Practices Awards have honoured best-in-class companies that have demonstrated excellence in their respective industries. Award recipients were identified based on in-depth interviews, analysis, and extensive secondary research conducted by Frost &Sullivan analysts and companies are typically studied on their revenues, market share, capabilities, and overall contribution to the industry in order to identify best practices.
With a strong overall performance, Avance Clinical earns the 2020 Asia-Pacific CRO Market Leadership Award. We also recognize that your receipt of this award is the result of many individuals (employees, customers and investors) making daily choices to believe in the organization and contribute in a meaningful way to its future.
About Avance Clinical
Australia's Avance Clinical Pty Ltd has more than 20-years of experience and is now one of Australia's leading Contract Research Organisations. Avance Clinical facilitates quality drug development by aligning people, skills, and expertise in the pursuit of drug development for a healthier world.
Avance Clinical is committed to providing high-quality clinical research services with its highly-experienced team. The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of experts who also demonstrate passion in their chosen field.
Avance Clinical offers high-quality services in an established clinical trial ecosystem, that includes world-class Investigators and Sites able to access specialised patient groups. Other benefits include:
1. The Government R&D grant means up to 43.5% rebate on clinical trial spend
2. Telehealth pivot during COVID-19 pandemic - speed and continuity
3. Site Initiation Visit (SIV) and Study Start achieved in 5 - 6 weeks
4. No IND required for clinical trials
5. Full GMP material is not mandated for Phase I clinical trials
6. An established clinical trial environment with world-class Investigators and sites
7. Established healthy subject databases and specialised patient populations
8. Five independent Phase 1 facilities across Australia including hospital-based units for critical care
9. Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with long track records in FDA compliant research
10. Seasonal studies: Northern hemisphere Sponsors can conduct their studies year-round taking advantage of Australia's counter-flu and allergy seasons
Media Contact:
media@avancecro.com
Chris Thompson
Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com
YouTuberジュキヤの動画企画が大炎上「普通に痴漢」「気持ち悪すぎ」
フジ元アナが苦言「女性アナウンサーはモノではなく人間です」一部記事“値付け”に
カブス鈴木誠也、メジャー初の満塁弾 6号同点グランドスラムで逆転勝ちに貢献
加藤紗里の意味深投稿にファンざわつく「結婚?」美男美女ショット公開し「ご報告」
ドジャース、着実な加点で山本由伸が6勝目! 大谷翔平は節目のメジャー通算100盗塁を達成
6勝目の山本由伸、靴紐が切れるアクシデントも「切れる予感はしてたっす」一問一答
壇蜜夫で漫画家の清野とおる氏 担当した広告を盗まれる「なるべく返してくだせえ」
【ソフトバンク】ロバート秋山、アルコ&ピース平子の「体格ブラザーズ」がセレモニアルピッチ
【楽天】ボートレーサー佐藤ほのかが始球式「ドジャースのグラスノーをイメージして投げました」
【阪神】左翼ミエセスの飛球キャッチに虎党ざわつき→大歓声 初回には同点機招く左前打後逸
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
柏原崇(45)現在を調べてみた結果、相変わらずかっこよすぎた!
大原櫻子、ガーシー暴露後初のSNS投稿に賛否の声「イメージ最悪になった」
玉置浩二の妻、青田典子(53)の現在がとんでもない事になっていると話題に
「暴露します」松本人志飲み会参加セクシー女優「衝撃作」発売「言えなくてずっと溜めてた」
浜崎あゆみ、子供の写真公開に疑いの声止まず「よそのお宅の子供?」
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
漫才師の今くるよさん死去 膵がんのため
大谷翔平被弾投手が悪態ついて退場処分!次打者フリーマンと対戦中に判定巡り塁審と口論
金正恩の妹・金与正関連のネタ投稿がTwitterで大量に出回る
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
柏原崇(45)現在を調べてみた結果、相変わらずかっこよすぎた!
玉置浩二の妻、青田典子(53)の現在がとんでもない事になっていると話題に
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
元めちゃイケメンバーの三中元克(32)現在は何をしているのか調べてみた!
TikTokを賑わす「フエラムネごめんなサイダー味」がセブンイレブンで再販!じゅるるマスカットも買うなら今!
小倉優子、不自然な“二重ライン”にネット騒然「やっぱり整形?」
ガーシーが綾野剛のLINE公開でネット騒然「ショック」「すごいエンタメ」
岡本夏生(56)、1600日ぶりにブログを更新した現在が衝撃
大原櫻子、ガーシー暴露後初のSNS投稿に賛否の声「イメージ最悪になった」
YouTuberジュキヤの動画企画が大炎上「普通に痴漢」「気持ち悪すぎ」
フジ元アナが苦言「女性アナウンサーはモノではなく人間です」一部記事“値付け”に
カブス鈴木誠也、メジャー初の満塁弾 6号同点グランドスラムで逆転勝ちに貢献
加藤紗里の意味深投稿にファンざわつく「結婚?」美男美女ショット公開し「ご報告」
ドジャース、着実な加点で山本由伸が6勝目! 大谷翔平は節目のメジャー通算100盗塁を達成
6勝目の山本由伸、靴紐が切れるアクシデントも「切れる予感はしてたっす」一問一答
壇蜜夫で漫画家の清野とおる氏 担当した広告を盗まれる「なるべく返してくだせえ」
【楽天】ボートレーサー佐藤ほのかが始球式「ドジャースのグラスノーをイメージして投げました」
【ソフトバンク】ロバート秋山、アルコ&ピース平子の「体格ブラザーズ」がセレモニアルピッチ
【阪神】左翼ミエセスの飛球キャッチに虎党ざわつき→大歓声 初回には同点機招く左前打後逸